News

News
Understanding adaptive functioning in autism

Understanding adaptive functioning in autism

Adaptive functioning refers to the ability to manage the demands of day-to-day life. It can include areas such as self-care, travel, shopping, cooking, fine motor skills and communication. It is understood that autistic people may learn some of these skills at a...

read more
AIMS-2-TRIALS’ response to COVID-19

AIMS-2-TRIALS’ response to COVID-19

We are all very shocked and saddened by the effect that COVID-19 is having globally. We hope you are keeping safe and well during these uncertain and difficult times. We understand that some of you will be more affected than others either by being ill yourself, having...

read more
Autistic people’s social brain activity is not reduced

Autistic people’s social brain activity is not reduced

An article in Molecular Autism by AIMS-2-TRIALS researchers will report that - contrary to predictions made by previous research – in an analysis of one of the largest data sets of its kind, no group differences were found in the brain activity of autistic and...

read more
Researcher training opportunities

Researcher training opportunities

The Early Career Researcher Autism Network was launched earlier this year at the AIMS-2-TRIALS general assembly - an event that saw over thirty researchers share ideas about their training needs. To promote training opportunities for researchers in an early stage of...

read more
Clinical trials begin at three AIMS-2-TRIALS sites

Clinical trials begin at three AIMS-2-TRIALS sites

Development of medicines is a key priority within the AIMS-2-TRIALS research programme and this will be achieved primarily via two clinical trials. A clinical trial is a specific type of research study that evaluates an intervention; in this case a medicine. The main...

read more
Prestigious scientific awards for consortium members

Prestigious scientific awards for consortium members

AIMS-2-TRIALS is celebrating prestigious awards received by two consortium members, both based at Kings College London. Oscar Marín, Director of the Centre for Developmental Neurobiology, was unanimously selected by an international jury to receive the Remedios Caro...

read more
A new publication for Autism-Europe

A new publication for Autism-Europe

Autism-Europe is an international autism association whose main objectives are to improve public awareness of autism and to advance the rights of autistic people and their families. In September, the third edition of their publication “People with Autism Spectrum...

read more
AIMS-2-TRIALS researchers at key events in Europe

AIMS-2-TRIALS researchers at key events in Europe

Autism Europe Congress Consortium members participated throughout the Autism Europe Congress 2019 on 13th - 15th September, delivering keynotes, moderating sessions and as part of the scientific committee. James Cusack (Autistica) chaired a keynote session on...

read more
Changing pupil size indicates social abilities in autism

Changing pupil size indicates social abilities in autism

The amount that autistic people’s pupils widen (dilate) when watching others interact and the speed at which this happens is linked with their understanding of social behaviour, shows a study led by AIMS-2-TRIALS researchers. The study is the first to record the...

read more
Declan Murphy & Gráinne McAlonan of KCL on BBC Radio 4

Declan Murphy & Gráinne McAlonan of KCL on BBC Radio 4

Declan Murphy and Gráinne McAlonan of Kings College London were recently featured on BBC Radio 4's 'D for Diagnosis' with Claudia Hammond, discussing the diagnosis of autism and co-occurring conditions. https://twitter.com/Aims2Trials/status/1158370309495578625

read more
Eye tracking holds clues to the emergence of autism

Eye tracking holds clues to the emergence of autism

Ten month old infants later diagnosed with autism use their gaze to attract other’s attention less often than those who are not autistic, shows research led by Terje Falck-Ytter at Uppsala University in Sweden, as part of AIMS-2-TRIALS. “Joint attention is extremely...

read more
Machine learning heralds a new era for autism research

Machine learning heralds a new era for autism research

Computer algorithms that can spot patterns in vast amounts of data will drive the future of autism research and help scientists to understand autism’s true complexity and diversity, say AIMS-2-TRIALS researchers in a recent review article. The algorithms’ power comes...

read more

An opportunity to influence European research

The Innovative Medicines Initiative (IMI) wants to hear from youApplications are open for a ‘pool of patient experts’, which will strengthen the role and voice of those with diseases and conditions addressed by IMI research. This will introduce the perspectives of...

read more

Autism Representatives chosen from nearly 100 applications

The recruitment of Autism Representatives for AIMS-2-TRIALS is now complete. In total, 96 applicants from 18 European countries (and one from the US) expressed interest in working with us. This included autistic people and family carers of autistic people. There were...

read more
Researchers reach out to the community

Researchers reach out to the community

AIMS-2-TRIALS researchers met with autistic people at events across Europe about the future of autism research. At Trinity College Dublin, Ireland, team members from the rare genetic conditions study led an event in February to foster two-way dialogue about the future...

read more